Subscribe To
WINT / Windtree to Present at Oppenheimer's 32nd Annual Healthcare Conference
Content Topics
Windtree
Present
Oppenheimer
32nd
Annual
Healthcare
Oppenheimer s
Conference
Stock
WINT
WINT News
By GlobeNewsWire
October 12, 2023
Windtree to Present at the ThinkEquity Conference on October 19th in New York City
WARRINGTON, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology more_horizontal
By InvestorPlace
April 20, 2023
Why Is Windtree Therapeutics (WINT) Stock Down 58% Today?
Windtree Therapeutics (NASDAQ: WINT ) stock is falling on Thursday after the company announced the departure of its Chairman of the Board of Directors more_horizontal
By InvestorPlace
April 17, 2023
Why Is Windtree Therapeutics (WINT) Stock Up 190% Today?
On an otherwise bearish day in the markets, many investors may be looking for some good news. For those on such a search, taking a look at some of the more_horizontal
By Zacks Investment Research
November 18, 2022
Windtree Therapeutics, Inc. (WINT) Upgraded to Buy: Here's Why
Windtree Therapeutics, Inc. (WINT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Ra more_horizontal
By Benzinga
March 22, 2022
Windtree Posts Mid-Stage Study Data On Lucinactant For COVID-19-Associated Respiratory Distress
Windtree Therapeutics Inc (NASDAQ: WINT) announced results from its Phase 2 study of lucinactant (KL4 surfactant) for severe COVID-19 associated ac more_horizontal
By GlobeNewsWire
March 10, 2022
Windtree to Present at Oppenheimer's 32nd Annual Healthcare Conference
WARRINGTON, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused o more_horizontal
By Benzinga
February 1, 2022
Why Are Windtree Therapeutics Shares Trading Higher Today?
Windtree Therapeutics Inc WINT has completed enrollment in its Phase 2 study of lucinactant for COVID-19 associated lung injury and acute respirato more_horizontal
By Benzinga
February 1, 2022
Why Are Windtree Therapeutics Shares Trading Higher Today?
Windtree Therapeutics Inc WINT has completed enrollment in its Phase 2 study of lucinactant for COVID-19 associated lung injury and acute respirato more_horizontal